Cargando…

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer

Despite recent advances in the treatment of non-small cell lung cancer (NSCLC), less than 10% of patients survive the first five years when the disease has already spread at primary diagnosis. Methods: Blood samples were taken from 118 NSCLC patients at primary diagnosis or at progression of the dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obermayr, Eva, Koppensteiner, Nina, Heinzl, Nicole, Schuster, Eva, Holzer, Barbara, Fabikan, Hannah, Weinlinger, Christoph, Illini, Oliver, Hochmair, Maximilian, Zeillinger, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620949/ https://www.ncbi.nlm.nih.gov/pubmed/34834576 http://dx.doi.org/10.3390/jpm11111225

Ejemplares similares

Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2019)

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
por: Illini, Oliver, et al.
Publicado: (2022)

Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
por: Hochmair, Maximilian, et al.
Publicado: (2019)

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
por: Sajdik, Constantin, et al.
Publicado: (2022)

Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis
por: Illini, Oliver, et al.
Publicado: (2022)

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
por: Welsch, Eva, et al.
Publicado: (2023)

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
por: Hochmair, Maximilian J., et al.
Publicado: (2020)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2019)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
por: Obermayr, Eva, et al.
Publicado: (2017)

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
por: Illini, Oliver, et al.
Publicado: (2022)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
por: Plangger, Adelina, et al.
Publicado: (2021)

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
por: Illini, Oliver, et al.
Publicado: (2021)

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
por: Obermayr, Eva, et al.
Publicado: (2010)

Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
por: Rath, Barbara, et al.
Publicado: (2023)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
por: Tserpeli, Victoria, et al.
Publicado: (2021)

Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells
por: STICKLER, SANDRA, et al.
Publicado: (2023)

Resistance to chemoimmunotherapy in non-small-cell lung cancer
por: Hochmair, Maximilian Johannes
Publicado: (2020)

Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance
por: Klameth, Lukas, et al.
Publicado: (2017)

Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
por: Maritschnegg, Elisabeth, et al.
Publicado: (2018)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
por: Hackner, Klaus, et al.
Publicado: (2021)

Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
por: Hochmair, Maximilian
Publicado: (2018)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial
por: Hasenburg, A., et al.
Publicado: (2021)

PARP inhibition causes premature loss of cohesion in cancer cells
por: Kukolj, Eva, et al.
Publicado: (2017)

tRNA(GlyGCC)-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
por: Panoutsopoulou, Konstantina, et al.
Publicado: (2021)

The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer – a multicenter study
por: Grimm, Christoph, et al.
Publicado: (2009)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib
por: Buder, Anna, et al.
Publicado: (2020)

Prognostic value of circulating tumor cells in esophageal cancer
por: Xu, Hai-Tao, et al.
Publicado: (2017)

CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence
por: LIETO, EVA, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mi7itu54d2spnhls4p57alj6od